This site is intended for healthcare professionals
Disease page

Idiopathic pulmonary fibrosis (IPF)

Read time: 5 mins
Last updated: 14th Jan 2021

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease. IPF is more common in elderly patients and over time as healthy lung tissue is replaced by altered extracellular matrix (fibrosis) the alveolar architecture is destroyed, leading to decreased lung function and finally respiratory failure and death.

EAACME accredited CME

Recognising and optimising care of IPF

Are you familiar with the symptoms of idiopathic pulmonary fibrosis (IPF)? Learn more about how to definitively diagnose IPF and find out how early diagnosis can benefit your patients. Plus improve your knowledge of the treatment options available to patients with IPF.

Receive 1 European CME credit (ECMEC®) for successful completion.

Accreditation date 16th March 2020.

Start CME

Although the cause of IPF is not clear, smoking, viral infections and previous family history of the condition are contributing factors. Patients with IPF often have chronic exertional dyspnoea, bibasilar lung crackles (‘Velcro’ crackles) and finger clubbing. Physicians should consider IPF in patients with these signs and a definitive diagnosis can be made based on characteristic imaging and histological patterns.

Treating IPF includes pharmacological and pulmonary rehabilitation approaches. Effective disease-modifying treatments are available which is why it is important to diagnose and treat IPF as early as possible. In extreme cases of IPF a lung transplant may be needed.

To find out how to recognise and treat idiopathic pulmonary fibrosis, visit our dedicated Learning Zone which contains further information and expert opinion on diagnosis and current IPF treatment guidelines.